Category - Pharma Industry News
Gilead to pay $745m for three oncology programmes from Arcus Biosciences
MHRA authorises Vumerity for multiple sclerosis patients
NICE recommends Inrebic for rare blood cancer
NICE recommends long-acting HIV therapy developed by ViiV Healthcare and Janssen
Biogen’s Aduhelm unlikely to get approval in Europe
NICE approves first long-acting jab for HIV to replace daily pills
Under-18s with COVID-19 in UK advised to wait 12 weeks for vaccine dose
Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’